Drugs of the Future Q4 Unclaimed
Drugs of the Future is an interdisciplinary biomedical research journal that publishes well-documented, peer-reviewed articles on topics emerging from the confluence of scientific fields including chemistry, biology, pharmacology, genomics and medicine. The journal identifies and anticipates new trends, advances and breakthroughs in basic, translational and clinical research, and includes the following sections: It has an SJR impact factor of 0,119.
Type: Journal
Type of Copyright:
Languages: English
Open Access Policy: Non Open Access
Type of publications:
Publication frecuency: -
- €
Inmediate OA- €
Embargoed OA0 €
Non OAMetrics
0,119
SJR Impact factor47
H Index0
Total Docs (Last Year)194
Total Docs (3 years)0
Total Refs25
Total Cites (3 years)193
Citable Docs (3 years)0.14
Cites/Doc (2 years)0.0
Ref/DocOther journals with similar parameters
Pharmaceutical Chemistry Journal Q4
Expert Review of Precision Medicine and Drug Development Q4
Adverse Drug Reaction Bulletin Q4
Annals of Cancer Research and Therapy Q4
Journal of Pharmacology and Pharmacotherapeutics Q4
Compare this journals
Aims and Scope
Best articles by citations
Penbutolol
View moreHalopredone Diacetate
View moreX-linked hypophosphatemia: Understanding and management
View moreMemantine
View moreDBCO
View moreProquazone
View moreL-10503
View moreLR 511
View moreLR 534
View moreDefactinib hydrochloride. Dual FAK1/PYK2 inhibitor, Treatment of non-small cell lung cancer, treatment of malignant mesothelioma, treatment of ovarian cancer
View moreAliflurane
View moreGemcadiol
View moreAlletorphine
View moreMorocromen
View moreNorgestimate
View moreD-32
View moreN-propylnoraporphine
View moreGYKI-13504
View moreClazolimine
View moreButibufen
View moreCartazolate
View moreGemfibrozil
View moreCloprednol
View moreTocainide
View more
Comments